Cited by 84Nanoparticle-Based Drug DeliveryCancer Research and TreatmentsAntimicrobial Resistance in Staphylococcus

Reconstructed apoptotic bodies as targeted "nano decoys" to treat intracellular bacterial infections within macrophages and cancer cells

Open access
Bose, Rajendran J. C., Tharmalingam, Nagendran, Garcia Marques, Fernando J., Sukumar, Uday Kumar, Natarajan, Arutselvan, Zeng, Yitian, Robinson, Elise, Bermudez, Abel +8 more·2020·ACS Nano

Abstract

Abstract Staphylococcus aureus (S. aureus) is a highly pathogenic facultative anaerobe that in some instances resides as an intracellular bacterium within macrophages and cancer cells. This pathogen can establish secondary infection foci, resulting in recurrent systemic infections that are difficult to treat using systemic antibiotics. Here, we use reconstructed apoptotic bodies (ReApoBds) derived from cancer cells as “nano decoys” to deliver vancomycin intracellularly to kill S. aureus by targeting inherent “eat me” signaling of ApoBds. We prepared ReApoBds from different cancer cells (SKBR3, MDA-MB-231, HepG2, U87-MG, and LN229) and used them for vancomycin delivery. Physicochemical characterization showed ReApoBds size ranges from 80 to 150 nm and vancomycin encapsulation efficiency of 60 ± 2.56%. We demonstrate that the loaded vancomycin was able to kill intracellular S. aureus efficiently in an in vitro model of S. aureus infected RAW-264.7 macrophage cells, and U87-MG (p53-wt) and LN229 (p53-mt) cancer cells, compared to free-vancomycin treatment (P < 0.001). The vancomycin loaded ReApoBds treatment in S. aureus infected macrophages showed a two-log-order higher CFU reduction than the free-vancomycin treatment group. In vivo studies revealed that ReApoBds can specifically target macrophages and cancer cells. Vancomycin loaded ReApoBds have the potential to kill intracellular S. aureus infection in vivo in macrophages and cancer cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsnano.0c00921

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intracellular bacterial reservoirs within host cells pose a critical challenge in osteomyelitis by facilitating immune evasion and reducing antibiotic clearance, contributing to recurrence of refractory infections.

    “Beyond biofilm formation, intracellular bacterial reservoirs within host cells pose a critical challenge in osteomyelitis by facilitating immune evasion and reducing antibiotic clearance, thereby contributing to the recurrence of refractory infections [40].”

    From Nanocatalytic magnesium osteoimplants with biodegradable self-adaptive interfaces for therapeutic repair of infected bone defects (2026) · cites this paper as [40]

    The Abstract (page not provided) says that intracellular S. aureus reservoirs can evade host defenses and seed recurrent infections. The Results and Discussion section (page not provided) says intracellular persistence may circumvent vancomycin treatment. The paper does not establish these effects specifically in osteomyelitis or link them to recurrent refractory bone infections. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [35]Bai C; Li D; Zhang Q; Zheng S; Wang H; Li L; Zhang W. Prognostic Analysis of Cancer Patients with Staphylococcus aureus Infection: Five-Year Experience at a Comprehensive Cancer Center. Int. J. Clin. Exp. Med 2018, 11, 8640– 8645.

Cited by

Sorted by citations

Authors
Bose, R. J. C., Tharmalingam, N., Garcia Marques, F. J., Sukumar, U. K., Natarajan, A., Zeng, Y., Robinson, E., Bermudez, A., Chang, E., Habte, F., Pitteri, S. J., McCarthy, J. R., Gambhir, S. S., Massoud, T. F., Mylonakis, E., & Paulmurugan, R.
Affiliations
  • Stanford Medicine (US)
  • Brown University (US)
  • Stanford University , , 3155 Porter Drive , , ,
  • Masonic Medical Research Laboratory (US)
Corresponding author
Paulmurugan, Ramasamy
Venue
ACS Nano
Published
2020-04-29
Volume
14
Issue
5
Pages
5818-5835
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W3020703473
Cited by
84
References
51
Citations by year
2026: 10 · 2025: 13 · 2024: 12 · 2023: 15 · 2022: 17 · 2021: 12 · 2020: 5
FWCI
3.19
Type
journal article
Language
en
Open access
Locations
  • ACS Nano (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (R01CA209888, U54 CA199075)
  • National Institute of Biomedical Imaging and Bioengineering (R21EB022298)
  • Ben and Catherine Ivy Foundation
  • Focused Ultrasound Foundation
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
Staphylococcus aureus, intracellular bacterial infection, macrophages, cancer cells, intracellular drug delivery, p53, targeted drug delivery, antibiotic resistance
MeSH terms
Extracellular Vesicles, Animals, Anti-Bacterial Agents, Macrophages, Microbial Sensitivity Tests, Neoplasms, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review